RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.94B
AUM Growth
-$52.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$54.6M
2
+$28.8M
3
+$27.6M
4
JBIO
Jade Biosciences
JBIO
+$27.2M
5
TYRA icon
Tyra Biosciences
TYRA
+$14.8M

Top Sells

1
+$58.6M
2
+$46.8M
3
+$45.6M
4
URGN icon
UroGen Pharma
URGN
+$35.5M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$32M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.77B 29.9%
10,281,496
2
$389M 6.55%
11,965,991
-223,158
3
$351M 5.92%
5,561,359
-523,053
4
$258M 4.35%
11,189,693
5
$206M 3.48%
7,266,031
+965,623
6
$200M 3.37%
3,036,527
7
$195M 3.29%
19,889,683
8
$190M 3.19%
10,860,977
9
$184M 3.09%
10,138,938
10
$181M 3.05%
10,445,322
11
$164M 2.76%
3,365,523
+2,272,727
12
$130M 2.19%
9,902,633
+993,542
13
$122M 2.06%
4,178,823
14
$118M 1.99%
18,202,009
15
$117M 1.97%
12,198,625
+1,561,335
16
$93.6M 1.58%
7,676,697
+732,049
17
$92.5M 1.56%
9,714,392
18
$85.1M 1.43%
60,379,366
19
$83.5M 1.41%
1,577,106
20
$83.2M 1.4%
6,147,280
21
$73.9M 1.25%
6,995,858
22
$70.4M 1.19%
10,229,099
23
$64.6M 1.09%
6,955,993
24
$64.2M 1.08%
1,982,302
25
$54.4M 0.92%
23,555,648
+12,683,145
1
2 3 4